Pharma 2023: Nuevas drogas que se lanzarán y aprobarán desde Agosto 2023 en Adelante. Sus proyecciones.
- netmd
- 13 de agosto de 2023
- Pharma Industry
- 0 Comments
Las Drogas que se lanzarán en 2023 desde Agosto en Adelante.
Descargue el Excel aqui:
COMPANY | COUNTRY | CURRENCY | MARKET CAP (Bn) | CHANGE IN MARKET CAP (M) | STOCK PRICE | CHANGE IN PRICE |
PeptiDream (4587.T) | Japan | JPY | 234,48 | -45.570 | 1.833 | -16,1% |
Merck & Co (MRK) | U.S.A | USD | 267,88 | -20.320 | 107 | -7,0% |
Apellis Pharmaceuticals (APLS) | U.S.A | USD | 4,01 | -6.871 | 32 | -64,8% |
Eli Lilly (LLY) | U.S.A | USD | 426,66 | -6.645 | 459 | -1,5% |
Bristol Myers Squibb (BMY) | U.S.A | USD | 130,13 | -6.300 | 62 | -4,6% |
Pfizer Inc (PFE) | U.S.A | USD | 202,44 | -5.650 | 36 | -2,7% |
Takeda Pharmaceutical (TAK) | Japan | USD | 48,11 | -3.110 | 15 | -6,3% |
Biogen (BIIB) | U.S.A | USD | 40,37 | -1.882 | 273 | -4,5% |
Moderna Therapeutics (MRNA) | U.S.A | USD | 46,74 | -1.525 | 119 | -3,3% |
Vir Biotechnology (VIR) | U.S.A | USD | 3,09 | -1.474 | 14 | -44,0% |
NovoCure (NVCR) | U.S.A | USD | 3,54 | -850 | 35 | -18,6% |
Horizon Therapeutics (HZNP) | Ireland | USD | 23,16 | -686 | 100 | -2,9% |
TG Therapeutics (TGTX) | U.S.A | USD | 3,21 | -598 | 21 | -16,0% |
Sarepta Therapeutics (SRPT) | U.S.A | USD | 9,84 | -466 | 109 | -4,4% |
Mirati Therapeutics (MRTX) | U.S.A | USD | 2,01 | -466 | 31 | -20,5% |
Madrigal Pharmaceuticals (MDGL) | U.S.A | USD | 3,95 | -439 | 208 | -10,3% |
Mersana Therapeutics (MRSN) | U.S.A | USD | 0,14 | -343 | 1 | -75,0% |
Alkermes Plc (ALKS) | Ireland | USD | 4,78 | -332 | 29 | -6,5% |
Theseus Pharmaceuticals (THRX) | U.S.A | USD | 0,13 | -305 | 3 | -70,0% |
Biohaven Pharmaceuticals (BHVN) | U.S.A | USD | 1,62 | -273 | 20 | -16,7% |
Akero Therapeutics (AKRO) | U.S.A | USD | 2,52 | -221 | 43 | -8,5% |
Seagen (SGEN) | U.S.A | USD | 37,05 | -188 | 193 | -0,5% |
Vaxcyte (PCVX) | U.S.A | USD | 4,55 | -187 | 48 | -4,0% |
Pacira BioSciences (PCRX) | U.S.A | USD | 1,74 | -184 | 36 | -10,0% |
Stoke Therapeutics (STOK) | U.S.A | USD | 0,29 | -177 | 7 | -36,4% |
Ventyx Biosciences (VTYX) | U.S.A | USD | 2,08 | -176 | 38 | -7,3% |
Replimune (REPL) | U.S.A | USD | 1,20 | -173 | 21 | -12,5% |
Ambrx Inc (AMAM) | U.S.A | USD | 0,89 | -121 | 15 | -11,8% |
Cytokinetics (CYTK) | U.S.A | USD | 3,34 | -96 | 33 | -2,9% |
Mineralys Therapeutics (MLYS) | U.S.A | USD | 0,63 | -82 | 15 | -11,8% |
Vigil Neuroscience (VIGL) | U.S.A | USD | 0,26 | -71 | 8 | -20,0% |
AEON Biopharma (AEON) | U.S.A | USD | 0,16 | -64 | 9 | -25,0% |
Emergent BioSolutions (EBS) | U.S.A | USD | 0,40 | -50 | 7 | -12,5% |
VBI Vaccines (VBIV) | U.S.A | USD | 0,03 | -46 | 1 | -66,7% |
Icosavax (ICVX) | U.S.A | USD | 0,39 | -41 | 9 | -10,0% |
Apogee Therapeutics (APGE) | U.S.A | USD | 0,99 | -34 | 21 | -4,5% |
Bicycle Therapeutics (BCYC) | United Kingdom | USD | 0,79 | -30 | 25 | -3,8% |
Tonix Pharmaceuticals Holding Corp (TNXP) | U.S.A | USD | 0,01 | -10 | 1 | -50,0% |
ADC Therapeutics (ADCT) | Switzerland | USD | 0,12 | 0 | 2 | 0,0% |
Astellas Pharma (ALPMY) | Japan | USD | 26,53 | 0 | 15 | 0,0% |
Beam Therapeutics (BEAM) | U.S.A | USD | 2,35 | 0 | 32 | 0,0% |
Biomea Fusion (BMEA) | U.S.A | USD | 0,81 | 0 | 22 | 0,0% |
Catalyst Pharmaceuticals (CPRX) | U.S.A | USD | 1,44 | 0 | 14 | 0,0% |
Generation Bio (GBIO) | U.S.A | USD | 0,33 | 0 | 5 | 0,0% |
Gilead Sciences (GILD) | U.S.A | USD | 96,28 | 0 | 77 | 0,0% |
Gossamer Bio (GOSS) | U.S.A | USD | 0,12 | 0 | 1 | 0,0% |
GSK (GSK) | United Kingdom | USD | 70,78 | 0 | 36 | 0,0% |
Hansoh Pharma (3692.HK) | China | HKD | 75,24 | 0 | 13 | 0,0% |
Intra-Cellular Therapies (ITCI) | U.S.A | USD | 6,09 | 0 | 63 | 0,0% |
Ionis Pharmaceuticals (IONS) | U.S.A | USD | 5,69 | 0 | 42 | 0,0% |
Mirum Pharmaceuticals (MIRM) | U.S.A | USD | 0,96 | 0 | 26 | 0,0% |
Paratek Pharmaceuticals (PRTK) | U.S.A | USD | 0,12 | 0 | 2 | 0,0% |
Poseida Therapeutics, Inc (PSTX) | U.S.A | USD | 0,16 | 0 | 2 | 0,0% |
Prothena (PRTA) | Ireland | USD | 3,38 | 0 | 69 | 0,0% |
PTC Therapeutics (PTCT) | U.S.A | USD | 3,04 | 0 | 42 | 0,0% |
Sangamo Therapeutics (SGMO) | U.S.A | USD | 0,23 | 0 | 1 | 0,0% |
Sanofi (SNY) | France | USD | 132,25 | 0 | 54 | 0,0% |
Santhera Pharmaceuticals (SANN.SW) | Switzerland | CHF | 0,10 | 0 | 9 | 0,0% |
Silence Therapeutics (SLNCF) | United Kingdom | USD | 0,09 | 0 | 1 | 0,0% |
Synaptogenix (SNPX) | U.S.A | USD | 0,01 | 0 | 1 | 0,0% |
Cabaletta Bio (CABA) | U.S.A | USD | 0,60 | 40 | 14 | 7,7% |
4D Molecular Therapeutics (FDMT) | U.S.A | USD | 0,75 | 42 | 19 | 5,6% |
Crinetics Pharmaceuticals (CRNX) | U.S.A | USD | 1,01 | 54 | 19 | 5,6% |
Phathom Pharmaceuticals (PHAT) | U.S.A | USD | 0,80 | 56 | 16 | 6,7% |
Novavax (NVAX) | U.S.A | USD | 0,70 | 86 | 9 | 12,5% |
Amphastar Pharmaceuticals (AMPH) | U.S.A | USD | 2,70 | 97 | 61 | 3,4% |
Nanobiotix (NBTX) | France | USD | 0,32 | 105 | 8 | 60,0% |
Castle Biosciences (CSTL) | U.S.A | USD | 0,43 | 107 | 18 | 28,6% |
Acumen Pharmaceuticals (ABOS) | U.S.A | USD | 0,26 | 123 | 8 | 60,0% |
Travere Therapeutics (TVTX) | U.S.A | USD | 1,18 | 149 | 18 | 12,5% |
Evelo Biosciences (EVLO) | U.S.A | USD | 0,22 | 150 | 11 | 266,7% |
Tarsus Pharmaceuticals (TARS) | U.S.A | USD | 0,66 | 161 | 24 | 33,3% |
Kiniksa Pharmaceuticals (KNSA) | U.S.A | USD | 1,36 | 175 | 19 | 35,7% |
BioMarin Pharmaceutical (BMRN) | U.S.A | USD | 16,12 | 188 | 88 | 1,1% |
Centessa Pharmaceuticals (CNTA) | U.S.A | USD | 0,76 | 191 | 8 | 33,3% |
BioNTech (BNTX) | Germany | USD | 26,09 | 241 | 110 | 0,9% |
Blueprint Medicines (BPMC) | U.S.A | USD | 3,48 | 242 | 68 | 6,3% |
Neuren Pharmaceuticals (NEU.AX) | Australia | AUD | 1,77 | 258 | 14 | 16,7% |
Caribou Biosciences (CRBU) | U.S.A | USD | 0,42 | 264 | 8 | 100,0% |
UroGen Pharma (URGN) | U.S.A | USD | 0,53 | 281 | 22 | 120,0% |
SpringWorks Therapeutics (SWTX) | U.S.A | USD | 1,87 | 313 | 32 | 18,5% |
Bio-Techne (TECH) | U.S.A | USD | 14,08 | 315 | 84 | 2,4% |
Immunocore (IMCR) | United Kingdom | USD | 2,93 | 370 | 67 | 13,6% |
Jazz Pharmaceuticals (JAZZ) | Ireland | USD | 8,09 | 385 | 131 | 4,8% |
Nuvalent (NUVL) | U.S.A | USD | 2,45 | 411 | 50 | 19,0% |
Immunovant (IMVT) | U.S.A | USD | 3,13 | 522 | 23 | 21,1% |
Evotec (EVO) | Germany | USD | 4,74 | 708 | 13 | 18,2% |
Neurocrine Biosciences (NBIX) | U.S.A | USD | 9,37 | 878 | 104 | 9,5% |
Halozyme Therapeutics (HALO) | U.S.A | USD | 5,03 | 922 | 44 | 18,9% |
United Therapeutics (UTHR) | U.S.A | USD | 10,98 | 937 | 245 | 8,9% |
Acadia Pharmaceuticals (ACAD) | U.S.A | USD | 5,23 | 976 | 30 | 25,0% |
Recursion Pharma (RXRX) | U.S.A | USD | 2,58 | 1.108 | 14 | 75,0% |
Alnylam Pharmaceuticals (ALNY) | U.S.A | USD | 24,54 | 1.245 | 200 | 5,3% |
Legend Biotech (LEGN) | U.S.A | USD | 12,63 | 1.262 | 76 | 10,1% |
Vertex Pharmaceuticals (VRTX) | U.S.A | USD | 92,20 | 1.288 | 354 | 1,4% |
Roivant Sciences (ROIV) | U.S.A | USD | 8,94 | 1.534 | 12 | 20,0% |
Reata Pharmaceuticals (RETA) | U.S.A | USD | 6,24 | 2.082 | 167 | 60,6% |
Regeneron Pharmaceuticals (REGN) | U.S.A | USD | 79,17 | 2.481 | 745 | 3,2% |
Genmab (GMAB) | Denmark | USD | 26,12 | 2.611 | 42 | 10,5% |
BridgeBio Pharma (BBIO) | U.S.A | USD | 5,48 | 2.889 | 36 | 100,0% |
Bayer AG (BAYN.DE) | Germany | EUR | 49,34 | 2.947 | 54 | 5,9% |
BeiGene (BGNE) | China | USD | 20,78 | 4.113 | 221 | 21,4% |
Novo Nordisk (NVO) | Denmark | USD | 360,66 | 4.480 | 162 | 1,3% |
Amgen Inc (AMGN) | U.S.A | USD | 121,52 | 5.343 | 236 | 4,4% |
F. Hoffmann-La Roche (RHHBY) | Switzerland | USD | 254,53 | 6.390 | 39 | 2,6% |
argenx (ARGX) | Netherlands | USD | 21,21 | 6.883 | 511 | 31,7% |
Novartis Pharmaceuticals Corporation (NVS) | Switzerland | USD | 209,71 | 10.600 | 105 | 5,0% |
AstraZeneca (AZN) | United Kingdom | USD | 208,86 | 15.500 | 72 | 7,5% |
Johnson & Johnson (JNJ) | U.S.A | USD | 413,38 | 15.600 | 170 | 3,7% |
AbbVie Inc (ABBV) | U.S.A | USD | 239,96 | 28.160 | 151 | 11,9% |
Otsuka Holdings (4578.T) | Japan | JPY | 2.815,00 | 104.728 | 5.507 | 3,6% |